title: Is cognitive decline measurable in preclinical Alzheimer's disease?
authors.affiliation: Cognitive Neurology and Alzheimer's Disease Center and Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
authors.forename: Sandra
authors.initials: S
authors.lastname: Weintraub
authors.affiliation: Department of Neurology, Loyola University Medical Center, Maywood, IL, USA.
authors.forename: Christopher
authors.initials: C
authors.lastname: Randolph
authors.affiliation: Independent Science Writer, Philadelphia, PA, USA.
authors.forename: Lisa
authors.initials: L
authors.lastname: Bain
authors.affiliation: Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA. Electronic address: jhendrix@alz.org.
authors.forename: James A
authors.initials: JA
authors.lastname: Hendrix
authors.affiliation: Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
authors.forename: Maria C
authors.initials: MC
authors.lastname: Carrillo
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000523:psychology*; D060825:Cognitive Dysfunction / Q000175:diagnosis*; D003226:Congresses as Topic; D006801:Humans; D062706:Prodromal Symptoms